Patent intelligence · US
US 11795130
Process for separating a constituent/cannabinoid using a chromatographic resin
Process for separating a constituent/cannabinoid using a chromatographic resin
Patent details — US 11795130
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 24, 2023
- Expiration
- Oct 19, 2043
- Applicant
- KAZMIRA LLC.
- Claims
- 40
- CPC classes
- A61K, A61K31/05, A61K31/192, A61K31/352
Quick answer
US 11795130 (Process for separating a constituent/cannabinoid using a chromatographic resin) is held by KAZMIRA LLC.. Status: granted. Granted Oct 24, 2023. Expires Oct 19, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- KAZMIRA LLC.
- Grant date
- Expiration
- Claims
- 40
- CPC classes
- A61K, A61K31/05, A61K31/192, A61K31/352, A61K31/658
More from KAZMIRA LLC.
Related pharmaceutical patents in our USPTO index.
-
US 12421228
Naphthyridine derivatives as PRC2 inhibitors
granted -
US 12421253
Tetrahydropyridopyrimidine pan-KRas inhibitors
granted -
US 12414911
Topical compositions and methods of use
granted -
US 12412764
Substrate-accommodating container
granted -
US 12398154
Azaquinazoline pan-KRas inhibitors
granted -
US 12383503
Adagrasib solid pharmaceutical compositions
granted -
US 12377101
Combination therapies
granted -
US 12371435
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
granted
Frequently asked questions
What is US patent 11795130?
US 11795130 (Process for separating a constituent/cannabinoid using a chromatographic resin) is held by KAZMIRA LLC.. Status: granted. Granted Oct 24, 2023. Expires Oct 19, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11795130?
KAZMIRA LLC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 308 pharmaceutical patents for this assignee.
When does US 11795130 expire?
Our index shows an expiration date of Oct 19, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.